triggered semaglutide How GLP-1 drugs work in brain cells: NIH study reveals weight-loss mechanisms Mast Cell Activation Syndrome (MCAS)

Estimates from World Health Organization indicates that over 750 million people are living with obesity and the global market for anti-obesity medications in 2023 reached $6 billion

Behavioral tools and structured tracking can really help make a big difference between short-lived results and lasting change

April 2025: Another study showed how semaglutide use may lead to a higher risk of vision impairment compared to other GLP-1 RA medications

Do More Movement General guidelines suggest 150 to 300 minutes of moderate-intensity aerobic exercise weekly, but maintaining weight loss while on semaglutide often requires exceeding those minimums

Semaglutide-related fatigue and GLP-1 tiredness may partially result from the same fluid deficits that cause dry mouth

Y en salud es todo